Fresenius Medical Care (FMS) PT Raised to $42 at RBC Capital
Tweet
Share
E-mailGet Alerts FMS Hot Sheet
Price: $20.21 -2.65%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Fresenius Medical Care (NYSE: FMS) to $42.00 (from $40.00) while maintaining a Sector Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Genuity Downgrades Antofagasta Plc. (ANTO:LN) (ANFGF) to Hold
- STMicroelectronics NV (STM:FP) (STM) PT Lowered to EUR37 at Barclays
- Stifel Upgrades LeMaitre Vascular (LMAT) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
